Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
The main purpose of this study is to look at how safe the study drug (mevidalen) is and whether it works to alleviate symptoms when given to people with mild to moderate Alzheimer Disease (AD) dementia. This is done by looking at participants: thinking and memory (cognition), everyday activities and sleep, AD symptoms, physical activity, irritability or anxiety. The study is expected to last approximately 26 weeks and may include up to 14 visits.
Sponsor: Eli Lilly and Company
Check if you qualify for this alzheimer's disease clinical trial in Little Rock, AR
If you're searching for alzheimer's disease treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.